Learning Objectives:
1. Review denosumab use in osteoporosis management.
2. Discuss the rebound phenomenon seen with denosumab discontinuation.
3. Review the treatment strategies used to mitigate the rebound phenomenon.
Session date:
05/20/2024 - 5:00pm to 6:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Leanne Duge, M.D.